Патогенетическое значениеи коррекция назальной обструкциипри аллергическом рините
Патогенетическое значениеи коррекция назальной обструкциипри аллергическом рините
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт, 1998.
2. Ильина Н.И., Польнер С.А. Круглогодичный аллергический ринит. Consilium medicum 2001; 3 (8): 384–93.
3. Лусс Л. В. Аллергический ринит: проблемы, диагностика, терапия. Леч. врач 2002; 4: 24–8.
4. Намазова Л.С., Вознесенская Н.И., Торшхоева Р.М., Эфендиева К.Е. Аллергический ринит. Consilium Medicum 2002; 5: 10.
5. Польнер С.А. Новое о сенной лихорадке. Энергия 2006; 6: 68–73.
6. Пыцкий В.И. и др. Аллергические заболевания. М.: Триада-Х, 1999.
7. Matsune S. et al. Hypoxia in paranasal sinuses of patients with chronic sinusitis with or without the complication of nasal allergy. Acta Otolaryngol 2003; 123 (4): 519–23.
8. Ogawa T et al. Submucous turbinectomy combined with posterior nasal neurectomy in the management of severe allergic rhinitis: clinical outcomes and local cytokine changes. Auris Nasus Larynx 2007; 34 (3): 319–26.
9. Scadding G. Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments. Paediatr Drugs 2008; 10 (3): 151–62.
10. Konstantinidis I et al. Long term results following nasal septal surgery. Focus on patients' satisfaction. Auris Nasus Larynx 2005; 32 (4): 369–74.
11. Roca-Ferrer J, Mullol J, Perez M et al. Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: comparison between human upper and lower airways. J Allergy Clin Immunol 2000; 106 (6): 1053–62.
12. Ursulovic D, Janosevic L, Janosevic S. Pharmacomodulation of hypersensitivity rhinitis. Med Pregl 2001; 54 (9–10): 476–8.
13. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002; 89 (5): 479–84.
14. Farid R, Farid F, Ghaffari J et al. Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis. Iran J Allergy Asthma Immunol 2003; 2 (4): 193–6.
15. Fairfax A, Hall I, Spelman R. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Ann Allergy Asthma Immunol 2001; 86 (5): 575–82.
16. Giger R, Pasche P, Cheseaux C et al. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2003; 260 (3): 135–40.
2. Ильина Н.И., Польнер С.А. Круглогодичный аллергический ринит. Consilium medicum 2001; 3 (8): 384–93.
3. Лусс Л. В. Аллергический ринит: проблемы, диагностика, терапия. Леч. врач 2002; 4: 24–8.
4. Намазова Л.С., Вознесенская Н.И., Торшхоева Р.М., Эфендиева К.Е. Аллергический ринит. Consilium Medicum 2002; 5: 10.
5. Польнер С.А. Новое о сенной лихорадке. Энергия 2006; 6: 68–73.
6. Пыцкий В.И. и др. Аллергические заболевания. М.: Триада-Х, 1999.
7. Matsune S. et al. Hypoxia in paranasal sinuses of patients with chronic sinusitis with or without the complication of nasal allergy. Acta Otolaryngol 2003; 123 (4): 519–23.
8. Ogawa T et al. Submucous turbinectomy combined with posterior nasal neurectomy in the management of severe allergic rhinitis: clinical outcomes and local cytokine changes. Auris Nasus Larynx 2007; 34 (3): 319–26.
9. Scadding G. Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments. Paediatr Drugs 2008; 10 (3): 151–62.
10. Konstantinidis I et al. Long term results following nasal septal surgery. Focus on patients' satisfaction. Auris Nasus Larynx 2005; 32 (4): 369–74.
11. Roca-Ferrer J, Mullol J, Perez M et al. Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: comparison between human upper and lower airways. J Allergy Clin Immunol 2000; 106 (6): 1053–62.
12. Ursulovic D, Janosevic L, Janosevic S. Pharmacomodulation of hypersensitivity rhinitis. Med Pregl 2001; 54 (9–10): 476–8.
13. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002; 89 (5): 479–84.
14. Farid R, Farid F, Ghaffari J et al. Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis. Iran J Allergy Asthma Immunol 2003; 2 (4): 193–6.
15. Fairfax A, Hall I, Spelman R. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. Ann Allergy Asthma Immunol 2001; 86 (5): 575–82.
16. Giger R, Pasche P, Cheseaux C et al. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. Eur Arch Otorhinolaryngol 2003; 260 (3): 135–40.
Авторы
Е.В.Носуля
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.